254 related articles for article (PubMed ID: 20945135)
1. Cytochrome P450 networks in chemical space.
Lee S; Kim D
Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
[TBL] [Abstract][Full Text] [Related]
2. Overview of human cytochrome P450 networks in chemical space.
Basith S; Choi S
Arch Pharm Res; 2010 Sep; 33(9):1289-91. PubMed ID: 20945125
[No Abstract] [Full Text] [Related]
3. Modulation of the cytochrome P450 system as a mechanism of chemoprotection.
Wolf CR; Mahmood A; Henderson CJ; McLeod R; Manson MM; Neal GE; Hayes JD
IARC Sci Publ; 1996; (139):165-73. PubMed ID: 8923029
[TBL] [Abstract][Full Text] [Related]
4. Automated information extraction and structure-activity relationship analysis of cytochrome P450 substrates.
Yamashita F; Feng C; Yoshida S; Itoh T; Hashida M
J Chem Inf Model; 2011 Feb; 51(2):378-85. PubMed ID: 21247177
[TBL] [Abstract][Full Text] [Related]
5. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes.
Ono S; Hatanaka T; Hotta H; Satoh T; Gonzalez FJ; Tsutsui M
Xenobiotica; 1996 Jul; 26(7):681-93. PubMed ID: 8819299
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of rat cytochrome P450 isoforms to the metabolism of caffeine: the pathway and concentration dependence.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Apr; 75(7):1538-49. PubMed ID: 18279840
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions.
Lee MD; Ayanoglu E; Gong L
Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918
[TBL] [Abstract][Full Text] [Related]
8. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
9. Designing better drugs: predicting cytochrome P450 metabolism.
de Groot MJ
Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
[TBL] [Abstract][Full Text] [Related]
10. A quantitative index of substrate promiscuity.
Nath A; Atkins WM
Biochemistry; 2008 Jan; 47(1):157-66. PubMed ID: 18081310
[TBL] [Abstract][Full Text] [Related]
11. In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver.
Katoh M; Matsui T; Nakajima M; Tateno C; Soeno Y; Horie T; Iwasaki K; Yoshizato K; Yokoi T
Drug Metab Dispos; 2005 Jun; 33(6):754-63. PubMed ID: 15769886
[TBL] [Abstract][Full Text] [Related]
12. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
13. Cataloging the Repertoire of Nature's Blowtorch, P450.
Guengerich FP
Chem Biol; 2009 Dec; 16(12):1215-6. PubMed ID: 20064429
[TBL] [Abstract][Full Text] [Related]
14. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
[TBL] [Abstract][Full Text] [Related]
15. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
Crivori P; Poggesi I
Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
[TBL] [Abstract][Full Text] [Related]
16. CYP12A1, a mitochondrial cytochrome P450 from the house fly.
Guzov VM; Unnithan GC; Chernogolov AA; Feyereisen R
Arch Biochem Biophys; 1998 Nov; 359(2):231-40. PubMed ID: 9808765
[TBL] [Abstract][Full Text] [Related]
17. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
Dong D; Wu B
Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and induction of human cytochrome P450 enzymes: current status.
Pelkonen O; Turpeinen M; Hakkola J; Honkakoski P; Hukkanen J; Raunio H
Arch Toxicol; 2008 Oct; 82(10):667-715. PubMed ID: 18618097
[TBL] [Abstract][Full Text] [Related]
19. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
[TBL] [Abstract][Full Text] [Related]
20. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
Shou M; Korzekwa KR; Krausz KW; Buters JT; Grogan J; Goldfarb I; Hardwick JP; Gonzalez FJ; Gelboin HV
Mol Carcinog; 1996 Dec; 17(4):241-9. PubMed ID: 8989918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
